4 models fit Universal Corporation Common Stock and they partly agree: 2 of 4 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Bronze48
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionUniversal Corporation Common Stock (UVV)
Fair value (4 models)
$58.61
ACCE price target
$42.00
Rating
Undervalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $57.90 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 29 Sept 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $39.29 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
33.0% below
+49.2% to fair value
ACCE score
33
out of 100
P/E
51.7x
forward 9.9x
1-year return
-26.6%
Dividend yield
8.37%
Universal Corporation Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Universal Corporation buys, processes and supplies leaf tobacco to cigarette makers, and has an ingredients business serving food and beverage customers. Long relationships with global manufacturers and sourcing in many countries make it a major supplier. The driver is crop supply and pricing, along with growth in ingredients. Revenue fell 11.8% with a 0.4% operating margin, so 12.0x forward earnings against 55.1x trailing suggests a recovery is expected.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Earnings collapse and margin deterioration
Earnings down 44.3% YoY; operating margin collapsed to 0.4% and net margin to 0.7%. Sequential revenue fell 26.8% QoQ, signalling sharp demand weakness.
high
ACCE score collapse
Score fell 10 points in 90 days (42 to 32). Quality and Momentum subscores particularly weak at 34 and 17 respectively, indicating deteriorating fundamentals.
moderate
Revenue contraction amid weak profitability
Annual revenue down 11.8% YoY despite 5y CAGR of 8.1%. ROE of 2.3% and operating margin of 0.4% leave little room for error or reinvestment.
moderate
Insider selling with no offsetting buys
Last 10 disclosures show $0.24M in insider sales and zero buys. Elevated short interest at 9.9% suggests scepticism among informed traders.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-10-10 · prices to Oct 23, 2026
Why it could do well
Consensus fair value of $57.90 implies 37.8% upside from the $42.00 share price across all 4 valuation models.
Free cash flow yield of 7.7% and dividend yield of 7.8% offer substantial income while the stock trades below analyst mean target of $67.00.
Why it could disappoint
Revenue fell 11.8% year over year and latest earnings missed expectations by 172%, signaling a severe destocking that may not reverse quickly.
Net margin of 0.7% and ROE of 2.3% leave almost no room for error if crop conditions worsen or input costs rise further.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where UVV's valuation models land
Price
$39.29
Model fair value
$58.61
Model range
$40.71 to $73.25
Fair value $58.61
Price $39.29
The price is below the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.